Metropolitan Life Insurance CO Athenex, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

38 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$1.36 - $2.94 $11,743 - $25,386
-8,635 Closed
0 $0
Q3 2021

Jun 21, 2023
BUY
$2.97 - $4.84 $25,645 - $41,793
8,635 New
8,635 $25,000
Q3 2021

Mar 30, 2023
SELL
$2.97 - $4.84 $51,829 - $84,462
-17,451 Reduced 66.9%
8,635 $25,000
Q3 2021

Nov 15, 2021
SELL
$2.97 - $4.84 $51,829 - $84,462
-17,451 Reduced 66.9%
8,635 $26,000
Q2 2021

Jun 21, 2023
BUY
$3.71 - $5.13 $96,779 - $133,821
26,086 New
26,086 $120,000
Q2 2021

Mar 30, 2023
BUY
$3.71 - $5.13 $71,877 - $99,388
19,374 Added 288.65%
26,086 $120,000
Q2 2021

Aug 16, 2021
BUY
$3.71 - $5.13 $96,753 - $133,785
26,079 Added 372557.12%
26,086 $121,000
Q1 2021

Jun 26, 2023
BUY
$4.08 - $14.75 $27,384 - $99,002
6,712 New
6,712 $28.9 Million
Q1 2021

Mar 30, 2023
SELL
$4.08 - $14.75 $56,426 - $203,992
-13,830 Reduced 67.33%
6,712 $28,000
Q1 2021

May 14, 2021
SELL
$4.08 - $14.75 $83,782 - $302,891
-20,535 Reduced 99.97%
7 $29,000
Q4 2020

Jun 22, 2023
BUY
$11.06 - $14.01 $227,194 - $287,793
20,542 New
20,542 $227,000
Q4 2020

Mar 30, 2023
SELL
$11.06 - $14.01 $10,562 - $13,379
-955 Reduced 4.44%
20,542 $227,000
Q4 2020

Feb 16, 2021
SELL
$11.06 - $14.01 $10,562 - $13,379
-955 Reduced 4.44%
20,542 $227,000
Q3 2020

Jun 26, 2023
BUY
$10.26 - $14.55 $220,559 - $312,781
21,497 New
21,497 $260,000
Q3 2020

Mar 30, 2023
SELL
$10.26 - $14.55 $10,290 - $14,593
-1,003 Reduced 4.46%
21,497 $260,000
Q3 2020

Nov 13, 2020
SELL
$10.26 - $14.55 $10,290 - $14,593
-1,003 Reduced 4.46%
21,497 $260,000
Q2 2020

Jun 26, 2023
BUY
$7.11 - $13.76 $159,975 - $309,600
22,500 New
22,500 $309,000
Q2 2020

Mar 30, 2023
SELL
$7.11 - $13.76 $1,016 - $1,967
-143 Reduced 0.63%
22,500 $309,000
Q2 2020

Aug 14, 2020
SELL
$7.11 - $13.76 $1,016 - $1,967
-143 Reduced 0.63%
22,500 $310,000
Q1 2020

Jul 12, 2023
BUY
$5.71 - $15.85 $129,291 - $358,891
22,643 New
22,643 $175,000
Q1 2020

Mar 30, 2023
BUY
$5.71 - $15.85 $5,978 - $16,594
1,047 Added 4.85%
22,643 $175,000
Q1 2020

May 15, 2020
BUY
$5.71 - $15.85 $5,978 - $16,594
1,047 Added 4.85%
22,643 $175,000
Q4 2019

Jul 12, 2023
BUY
$9.6 - $17.75 $207,321 - $383,329
21,596 New
21,596 $329,000
Q4 2019

Mar 30, 2023
SELL
$9.6 - $17.75 $9,667 - $17,874
-1,007 Reduced 4.46%
21,596 $329,000
Q4 2019

Feb 14, 2020
SELL
$9.6 - $17.75 $9,667 - $17,874
-1,007 Reduced 4.46%
21,596 $330,000
Q3 2019

Jul 12, 2023
BUY
$12.16 - $21.0 $274,852 - $474,663
22,603 New
22,603 $274,000
Q3 2019

Mar 30, 2023
BUY
$12.16 - $21.0 $101,633 - $175,518
8,358 Added 58.67%
22,603 $274,000
Q3 2019

Nov 14, 2019
BUY
$12.16 - $21.0 $101,633 - $175,518
8,358 Added 58.67%
22,603 $275,000
Q2 2019

Jul 12, 2023
BUY
$9.44 - $19.8 $145,885 - $305,989
15,454 New
15,454 $305,000
Q1 2019

Jul 13, 2023
BUY
$11.11 - $13.49 $158,261 - $192,165
14,245 New
14,245 $174,000
Q1 2019

Mar 30, 2023
BUY
$11.11 - $13.49 $158,261 - $192,165
14,245 New
14,245 $174,000
Q1 2019

May 16, 2019
BUY
$11.11 - $13.49 $111,966 - $135,952
10,078 Added 241.85%
14,245 $174,000
Q1 2019

May 15, 2019
SELL
$11.11 - $13.49 $111,966 - $135,952
-10,078 Reduced 70.75%
4,167 $365,000
Q4 2018

Jul 13, 2023
BUY
$10.24 - $15.49 $145,868 - $220,655
14,245 New
14,245 $180,000
Q4 2018

Feb 14, 2019
BUY
$10.24 - $15.49 $113,920 - $172,326
11,125 Added 356.57%
14,245 $181,000
Q3 2018

Jul 13, 2023
BUY
$15.53 - $19.97 $221,224 - $284,472
14,245 New
14,245 $221 Million
Q3 2018

Nov 14, 2018
SELL
$15.53 - $19.97 $172,771 - $222,166
-11,125 Reduced 78.1%
3,120 $48,000
Q2 2018

Aug 15, 2018
BUY
$15.88 - $19.5 $226,210 - $277,777
14,245 New
14,245 $0

Others Institutions Holding ATNX

# of Institutions
3
Shares Held
1.46M
Call Options Held
0
Put Options Held
0
View Full List

About Athenex, Inc.

ATNX Quotes by TradingView
  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email